ENDRA Life Sciences (NDRA) Short Interest Ratio & Short Volume → The new financial threat that could wipe out millions… (From InvestorPlace) (Ad) Free NDRA Stock Alerts $0.30 -0.02 (-6.21%) (As of 05/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media ENDRA Life Sciences Short Interest DataCurrent Short Volume7,600 sharesPrevious Short Volume30,600 sharesChange Vs. Previous Month-75.16%Dollar Volume Sold Short$1,991.20Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Outstanding Shares11,040,000 sharesFloat Size10,880,000 sharesShort Percent of Float0.07%Today's Trading Volume36,737 sharesAverage Trading Volume159,083 sharesToday's Volume Vs. Average23% Short Selling ENDRA Life Sciences ? Sign up to receive the latest short interest report for ENDRA Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNDRA Short Interest Over TimeNDRA Days to Cover Over TimeNDRA Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ENDRA Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20247,600 shares $1,991.20 -75.2%0.1%0 $0.26 3/31/202430,600 shares $17,748.00 -36.9%0.3%0.2 $0.58 3/15/202448,500 shares $48,500.00 -11.3%0.5%0.3 $1.00 2/29/202454,700 shares $61,264.00 +86.1%0.5%0.4 $1.12 2/15/202429,400 shares $33,810.00 +47.7%0.4%0.3 $1.15 1/31/202419,900 shares $20,895.00 -73.7%0.2%0.2 $1.05 Get the Latest News and Ratings for NDRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/202475,700 shares $98,410.00 -41.8%0.9%0.8 $1.30 12/31/2023130,000 shares $275,600.00 -25.5%1.6%1.4 $2.12 12/15/2023174,500 shares $251,280.00 -17.3%2.1%2.3 $1.44 11/30/2023211,100 shares $206,434.69 -11.8%2.6%1.9 $0.98 11/15/2023239,300 shares $227,335.00 -6.1%2.9%2.4 $0.95 10/31/2023254,900 shares $251,076.50 +56.5%3.5%2.2 $0.99 10/15/2023162,900 shares $169,416.00 +28.9%2.2%1.4 $1.04 9/30/2023126,400 shares $140,316.64 +175.4%1.7%1.1 $1.11 9/15/202345,900 shares $56,457.00 -37.1%0.6%0.4 $1.23 8/31/202373,000 shares $85,410.00 +5.5%1.0%1.2 $1.17 8/15/202369,200 shares $79,580.00 +61.7%0.9%1.1 $1.15 7/31/202342,800 shares $53,072.00 -20.0%0.6%0.8 $1.24 7/15/202353,500 shares $72,760.00 -36.5%0.7%0.8 $1.36 6/30/202384,300 shares $118,020.00 +13.2%1.2%1.3 $1.40 6/15/202374,500 shares $109,515.00 +40.0%1.0%1.4 $1.47 5/31/202353,200 shares $78,204.00 +54.7%0.8%1.2 $1.47 5/15/202334,400 shares $44,032.00 -70.1%0.5%1 $1.28 4/30/2023114,900 shares $183,840.00 +61.2%1.9%3.9 $1.60 4/15/202371,300 shares $131,905.00 +124.2%2.4%5.7 $1.85 3/31/202331,800 shares $72,818.82 -7.8%1.1%2.6 $2.29 3/15/202334,500 shares $124,200.00 +24.1%1.2%2.6 $3.60 2/28/202327,800 shares $108,420.00 -7.6%0.9%1.3 $3.90 2/15/202330,100 shares $111,370.00 -9.1%1.0%1.4 $3.70 1/31/202333,100 shares $132,731.00 -23.2%1.1%1.4 $4.01 1/15/202343,100 shares $202,570.00 +28.3%1.4%1.8 $4.70 12/30/202233,600 shares $136,752.00 -54.4%1.1%1.4 $4.07 12/15/202273,600 shares $374,624.00 +173.6%2.4%3.2 $5.09 11/30/202226,900 shares $4,777.44 -95.5%0.9%2 $0.18 11/15/2022597,800 shares $119,679.56 +8.8%N/A2.2 $0.20 10/31/2022549,600 shares $126,408.00 -19.7%N/A1.9 $0.23 10/15/2022684,800 shares $208,521.60 -11.7%N/A2.1 $0.30 9/30/2022775,300 shares $237,241.80 +0.1%N/A2.1 $0.31 9/15/2022774,500 shares $278,820.00 +11.5%N/A1.9 $0.36 8/31/2022694,700 shares $202,643.99 -8.8%N/A1.5 $0.29The #1 lithium battery stock to have on your radar in 2024! (Ad)Discover Why Zacks Small Cap Research Issued a “STRONG BUY” Rating on this Little-Known NASDAQ-traded Green Energy Company!Learn More Here NDRA Short Interest - Frequently Asked Questions What is ENDRA Life Sciences' current short interest? Short interest is the volume of ENDRA Life Sciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 7,600 shares of NDRA short. 0.07% of ENDRA Life Sciences' shares are currently sold short. Learn More on ENDRA Life Sciences' current short interest. What is a good short interest percentage for ENDRA Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.07% of ENDRA Life Sciences' floating shares are currently sold short. Is ENDRA Life Sciences' short interest increasing or decreasing? ENDRA Life Sciences saw a drop in short interest in April. As of April 15th, there was short interest totaling 7,600 shares, a drop of 75.2% from the previous total of 30,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ENDRA Life Sciences' float size? ENDRA Life Sciences currently has issued a total of 11,040,000 shares. Some of ENDRA Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ENDRA Life Sciences currently has a public float of 10,880,000 shares. How does ENDRA Life Sciences' short interest compare to its competitors? 0.07% of ENDRA Life Sciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to ENDRA Life Sciences: Nuwellis, Inc. (12.45%), Helius Medical Technologies, Inc. (8.52%), Tivic Health Systems, Inc. (4.19%), Aethlon Medical, Inc. (1.31%), Assure Holdings Corp. (2.04%), Clever Leaves Holdings Inc. (0.61%), Tenon Medical, Inc. (1.82%), Finch Therapeutics Group, Inc. (1.96%), Acutus Medical, Inc. (2.92%), Atreca, Inc. (0.37%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short ENDRA Life Sciences stock? Short selling NDRA is an investing strategy that aims to generate trading profit from ENDRA Life Sciences as its price is falling. NDRA shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ENDRA Life Sciences? A short squeeze for ENDRA Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NDRA, which in turn drives the price of the stock up even further. How often is ENDRA Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NDRA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NUWE Short Interest HSDT Short Interest TIVC Short Interest AEMD Short Interest IONM Short Interest CLVR Short Interest TNON Short Interest FNCH Short Interest AFIB Short Interest BCEL Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NDRA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyAI “wealth window” is closing June 25thParadigm Press